JP2006528221A5 - - Google Patents

Download PDF

Info

Publication number
JP2006528221A5
JP2006528221A5 JP2006529819A JP2006529819A JP2006528221A5 JP 2006528221 A5 JP2006528221 A5 JP 2006528221A5 JP 2006529819 A JP2006529819 A JP 2006529819A JP 2006529819 A JP2006529819 A JP 2006529819A JP 2006528221 A5 JP2006528221 A5 JP 2006528221A5
Authority
JP
Japan
Prior art keywords
bicalutamide
granule
dosage form
crystalline
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006529819A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006528221A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/005189 external-priority patent/WO2004100944A1/en
Publication of JP2006528221A publication Critical patent/JP2006528221A/ja
Publication of JP2006528221A5 publication Critical patent/JP2006528221A5/ja
Withdrawn legal-status Critical Current

Links

JP2006529819A 2003-05-14 2004-05-13 ビカルタミドの形態、組成物、およびその製造方法 Withdrawn JP2006528221A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47022403P 2003-05-14 2003-05-14
PCT/EP2004/005189 WO2004100944A1 (en) 2003-05-14 2004-05-13 Bicalutamide forms, compositions, and processes thereof

Publications (2)

Publication Number Publication Date
JP2006528221A JP2006528221A (ja) 2006-12-14
JP2006528221A5 true JP2006528221A5 (cg-RX-API-DMAC7.html) 2007-06-21

Family

ID=33452382

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006529819A Withdrawn JP2006528221A (ja) 2003-05-14 2004-05-13 ビカルタミドの形態、組成物、およびその製造方法

Country Status (9)

Country Link
US (1) US20050008691A1 (cg-RX-API-DMAC7.html)
EP (1) EP1622604A1 (cg-RX-API-DMAC7.html)
JP (1) JP2006528221A (cg-RX-API-DMAC7.html)
AU (1) AU2004238038A1 (cg-RX-API-DMAC7.html)
CA (1) CA2525318A1 (cg-RX-API-DMAC7.html)
FI (1) FI7526U1 (cg-RX-API-DMAC7.html)
NO (1) NO20055943L (cg-RX-API-DMAC7.html)
WO (1) WO2004100944A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200509152B (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE452637T1 (de) 2001-01-29 2010-01-15 Shionogi & Co Arzneipräparat, das als wirkstoff 5-methyl-1- phenyl-2-(1h)-pyridon enthält
US20040063782A1 (en) * 2002-09-27 2004-04-01 Westheim Raymond J.H. Bicalutamide forms
DK1775285T3 (da) * 2004-07-14 2011-11-21 Sumitomo Chemical Co Fremgangsmåde til krystallisation af bicalutamid
JP2008534575A (ja) * 2005-03-29 2008-08-28 ユーエスヴィー リミテッド ビカルタミドの調製のための新規プロセス
US7785629B2 (en) 2005-06-21 2010-08-31 Helm Ag Bicalutamide-adsorbates, process for preparing same, and pharmaceutical compositions thereof
US20070014854A1 (en) * 2005-07-15 2007-01-18 Ilan Zalit Novel granulation process
WO2007011349A1 (en) * 2005-07-15 2007-01-25 Teva Pharmaceutical Industries Ltd. Novel granulation process and granulate produced therefrom
US20070014853A1 (en) * 2005-07-15 2007-01-18 Ilan Zalit Pharmaceutical dosage form containing novel pharmaceutical granulate
US20070014864A1 (en) * 2005-07-15 2007-01-18 Teva Pharmaceutical Industries, Ltd. Novel pharmaceutical granulate
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
NZ591443A (en) * 2005-09-22 2013-04-26 Intermune Inc Granule formation of pirfenidone and pharmaceutically acceptable excipients
CZ299577B6 (cs) * 2005-12-20 2008-09-03 Interpharma Praha, A. S. Zpusob výroby vysoce cistého 4-kyano-3-trifluoromethyl-N-(3-p-fluorfenylsulfonyl-2-hydroxy-2-methylpropionyl) anilinu
US20070148245A1 (en) * 2005-12-22 2007-06-28 Ilan Zalit Compressed solid dosage forms with drugs of low solubility and process for making the same
WO2007104034A2 (en) 2006-03-08 2007-09-13 Takeda San Diego, Inc. Glucokinase activators
EP2049518B1 (en) 2006-05-31 2011-08-31 Takeda San Diego, Inc. Indazole and isoindole derivatives as glucokinase activating agents.
CA2655541A1 (en) * 2006-07-07 2008-06-12 Panacea Biotec Ltd. Methods and compositions for producing anti-androgenic effects
US20080045600A1 (en) * 2006-08-17 2008-02-21 Gawande Rahul S Bicalutamide compositions
JP2010503663A (ja) * 2006-09-15 2010-02-04 エコ・ファーマシューティカルズ・ビー．ブイ． 医薬活性物質を含む顆粒剤とその製造方法
AU2007295179B2 (en) * 2006-09-15 2013-05-30 Echo Pharmaceuticals B.V. Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
WO2008079787A2 (en) 2006-12-20 2008-07-03 Takeda San Diego, Inc. Glucokinase activators
GB0702826D0 (en) * 2007-02-14 2007-03-28 Pliva Istrazivanje I Razvoj D Preparation and composition of solid dosage form containing Bicalutamide
WO2008116107A2 (en) 2007-03-21 2008-09-25 Takeda San Diego, Inc. Piperazine derivatives as glucokinase activators
ES2855426T3 (es) * 2008-09-17 2021-09-23 Mylan Inc Granulados, proceso de preparación de los mismos y productos farmacéuticos que los contienen
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
JP7525264B2 (ja) * 2017-04-28 2024-07-30 リベルタス バイオ，インコーポレイティド アトピー性皮膚炎の治療及び原薬の安定性を向上するための製剤、方法、キット、及び剤形

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE28864T1 (de) * 1982-07-23 1987-08-15 Ici Plc Amide-derivate.
DE68916983T2 (de) * 1988-02-25 1995-01-19 Yamanouchi Europ Bv Verfahren zur Herstellung eines pharmazeutischen Granulats.
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
EP0748220A4 (en) * 1994-01-21 1997-09-10 Sepracor Inc METHOD AND COMPOSITIONS FOR TREATING ANDROGEN-DEPENDENT DISEASES USING OPTICALLY PURE R - (-) CASODEX
WO1998055153A1 (en) * 1997-06-04 1998-12-10 The University Of Tennessee Research Corporation Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
HU223950B1 (hu) 1999-06-10 2005-03-29 Richter Gedeon Vegyészeti Gyár Rt. Eljárás a racém, valamint az R-(-)- és S-(+)-N-[4-ciano-3-(trifluor-metil)-fenil]-3-[(4-fluor-fenil)-szulfonil]-2-hidroxi-2-metil-propánsavamid előállítására
US20040067257A1 (en) * 2001-02-27 2004-04-08 Nicola Bateman Pharmaceutical formulation
SK12032003A3 (sk) * 2001-04-02 2004-03-02 Astrazeneca Ab Farmaceutická formulácia obsahujúca 4'-kyano-alfa', alfa', alfa'-trifluór-3-(4-fluórfenylsulfonyl)-2-hydroxy-2- metylpropiono-m-toluidín a PVP
US6458769B1 (en) * 2001-06-25 2002-10-01 Astrazeneca Ab Amorphous compound
SE0103838D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Pharmaceutical formulation & product
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
US20040063782A1 (en) * 2002-09-27 2004-04-01 Westheim Raymond J.H. Bicalutamide forms

Similar Documents

Publication Publication Date Title
JP2006528221A5 (cg-RX-API-DMAC7.html)
ES2283821T3 (es) Composicioon farmaceutica solida que contiene un principio activo lipofilo y su procedimiento de preparacion.
TWI673051B (zh) 恩雜魯它脈（ｅｎｚａｌｕｔａｍｉｄｅ）之調和物
JP5209492B2 (ja) 速崩性錠剤製造のための医薬製剤
CN1479611A (zh) 包含酸不稳定活性成分的糊剂形式的药物制剂
KR20100117097A (ko) 생체 이용율이 개선된 엔타카폰, 레보도파 및 카르비도파의 약학 조성물
KR20170125944A (ko) 고체 분산액
JP2006528221A (ja) ビカルタミドの形態、組成物、およびその製造方法
TW200902089A (en) Solid pharmaceutical composition
JP2011148816A (ja) 口腔内速崩壊性錠
JP2007145856A (ja) カルベジロール製剤
WO2016159267A1 (ja) ミラベグロン含有医薬組成物
CN100528232C (zh) 包含酸不稳定活性成分的混悬液形式的药物制剂
JP2008531614A5 (cg-RX-API-DMAC7.html)
JP2008528456A (ja) 親油性結晶性物質としてカンデサルタンシレキセチルを含む新規な医薬組成物
KR890000182B1 (ko) 액상 윤활제-함유 약제학적 조성물 및 약제학적 제형의 용해도 개선방법
ES2625012T3 (es) Producto de comicronización que comprende un modulador selectivo del receptor de progesterona
JP2001503734A (ja) カリウム、ナトリウムおよびトリスオキサプロジン塩医薬組成物
KR101519612B1 (ko) 옥스카르바제핀을 포함하는 방출 제어형 고체 제제의 제조 방법 및 그에 의해 얻어질 수 있는 제제
BRPI0617180A2 (pt) formulaÇço de ibuprofeno capaz de ser transformada diretamente em tabletes, processo para produzir formulaÇÕes de ibuprofeno, e, forma de dosagem farmacÊutica
EP2566449A2 (en) Pharmaceutical compositions comprising ceftibuten
KR101532810B1 (ko) 당 알콜과 공동 미세화된 엔타카폰의 약학 조성물
JP2990562B2 (ja) 制酸剤組成物
JP5900702B2 (ja) 経口投与用医薬組成物
WO2015199115A1 (ja) 経口投与用医薬組成物